These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6994776)

  • 1. Elimination of guanfacine in patients with normal and impaired renal function.
    Kirch W; Köhler H; Braun W
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):33S-35S. PubMed ID: 6994776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of renal function on plasma concentration, urinary excretion and antihypertensive effect of guanfacine.
    Kirch W; Köhler H; Braun W; von Gizycki C
    Clin Pharmacokinet; 1980; 5(5):476-83. PubMed ID: 6996890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
    Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
    Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of guanfacine in patients undergoing haemodialysis.
    Kirch W; Kohler H; Axthelm T
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):277-80. PubMed ID: 6762301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of guanfacine in patients with impaired renal function and in some elderly patients.
    Kiechel JR
    Am J Cardiol; 1986 Mar; 57(9):18E-21E. PubMed ID: 3513525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of guanfacine in man: a review.
    Kiechel JR
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):25S-32S. PubMed ID: 6994775
    [No Abstract]   [Full Text] [Related]  

  • 8. Steady-state plasma levels and pharmacokinetics of guanfacine in patients with renal insufficiency.
    Carchman SH; Sica DA; Davis J; Crowe JT; Wasserman AJ; Proctor JD; Wright GJ
    Nephron; 1989; 53(1):18-23. PubMed ID: 2674741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers.
    Carchman SH; Crowe JT; Wright GJ
    J Clin Pharmacol; 1987 Oct; 27(10):762-7. PubMed ID: 3323255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
    Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanfacine kinetics in patients with hypertension.
    Weiss YA; Lavene DL; Safar ME; Simon AC; Loria Y; Georges DR; Milliez PL
    Clin Pharmacol Ther; 1979 Mar; 25(3):283-93. PubMed ID: 761440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-dependent blood pressure effects of guanfacine.
    Frisk-Holmberg M; Wibell L
    Clin Pharmacol Ther; 1986 Feb; 39(2):169-72. PubMed ID: 2867846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of guanfacine in the rabbit.
    Barber ND; Reid JL
    J Pharm Pharmacol; 1983 Feb; 35(2):114-5. PubMed ID: 6131978
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
    Toon S; Ross CE; Gokal R; Rowland M
    Br J Clin Pharmacol; 1990 Feb; 29(2):221-6. PubMed ID: 2306414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
    Sorkin EM; Heel RC
    Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May; 29(740):49-50. PubMed ID: 2883560
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure.
    Kiechel JR; Lavene D; Guerret M; Comoy E; Godin M; Fillastre JP
    Eur J Clin Pharmacol; 1983; 25(4):463-6. PubMed ID: 6360692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O; Polívková H
    Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.